What they were paid
MYRIAD GENETICS Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $98,000 | $244,996 | — | — | $342,996 |
| FY2024 | $98,000 | $349,999 | $0 | $0 | $447,999 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MYRIAD GENETICS INC DEF 14A filed April 14, 2026, accession 0000899923-26-000031, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025MYRIAD GENETICS pays directors a $60,000 cash retainer and $350,000 in RSUs.
Committees
FY2025 · as the proxy prints themCompensation · Nominating/Governance · Research and Product Innovation (Chair) · Leadership · Healthcare Industry · Diagnostic Industry · Research and Development · Provider or Payer Perspective
The rest of the MYRIAD GENETICS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Colleen F. Reitan | Independent Director | $338,496 |
| Daniel M. Skovronsky | Independent Director | $328,496 |
| Heiner Dreismann | Independent Director | $338,496 |
| Mark S. Davis | Independent Director | $211,932 |
| Paul M. Bisaro | Independent Director | $334,247 |
| Rashmi Kumar | Independent Director | $328,496 |
| S. Louise Phanstiel | Chair of the Board | $450,996 |
| Samraat S. Raha | Director | $0 |
The full MYRIAD GENETICS compensation record
free company briefThis page is one director within MYRIAD GENETICS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat